LNTH ($LNTH) Insider Trading & Smart Money Activity

LNTH · Drug Manufacturers - Specialty & Generic · Latest filing May 15, 2026

$LNTH has 2 13F position changes on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
2
Analyst ratings on file
0

LNTH insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 2 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All LNTH insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Farallon Capital Management Added +156K sh $583.59M +9.7%+11.5% —
13F Farallon Capital Management Added +156K sh $619.43M +9.7%+11.5% Read

1W / 1M / 6M = how LNTH moved from the trade or filing date.

Institutions moving LNTH (13F)

Frequently asked questions

Which institutions changed their LNTH positions?

Recent 13F filers moving the stock include Farallon Capital Management.

Other drug manufacturers - specialty & generic stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text